Tag: NASDAQ:BKR
-
Tesla Surges 12% with 2025 Affordable Vehicle Promise, Evotec Slumps 36% on Uncertain Outlook, and Latest Earnings
Tesla (NASDAQ:TSLA) – Tesla shares rose 11.96% in pre-market trading on Wednesday, even though its first-quarter earnings were below analysts’ forecasts. Tesla reported an adjusted earnings per share of 45 cents with revenues of $21.3 billion, while analysts had expected earnings per share of 51 cents and revenues of $22.15 billion. Moreover, Tesla revealed plans…
-
U.S. Index Futures Rise in Pre-Market, Oil Prices Dip Slightly
U.S. index futures saw a rise in pre-market trading this Tuesday, sustaining the positive momentum observed in the previous session. The S&P 500 broke a six-day losing streak the day before, driven by a significant recovery in the technology sector. At 6:33 AM, Dow Jones futures (DOWI:DJI) rose 69 points, or 0.19%. S&P 500 futures…
-
Wall Street Highlights: eBay Slashes 9% of Workforce, SAP to Reduce 8,000 Positions, and More
In the pre-market on Wednesday, U.S. index futures are showing positive performance, boosted by favorable results presented by Netflix (NASDAQ:NFLX). This optimism also anticipates the financial announcements expected from IBM (NYSE:IBM) and Tesla (NASDAQ:TSLA). At 05:38 AM, the futures of the Dow Jones (DOWI:DJI) rose 49 points, or 0.13%. S&P 500 futures rose 0.41% and…
-
Thursday’s Wall Street Highlights: Tesla, Apple, TSMC, Netflix, Pfizer, J&J, and more
US Index Futures operate without a defined direction, as investors digest mixed earnings from last night and await more numbers. By 07:01 AM, Dow Jones futures (DOWI:DJI) were up 41 points, or 0.12%. S&P 500 futures were down -0.11%, while Nasdaq-100 futures were down -0.65%. The 10-year Treasury yield is at 3.789%. In Europe, the producer price…
-
FTC to Block Amgen’s Acquisition, Home Depot Anticipates Sales Decline, Venture Funds’ Negative Returns
FTC to Block Amgen’s Acquisition The Federal Trade Commission (FTC) is set to block Amgen’s (NASAQ:MAGN) proposed acquisition of Horizon Therapeutics (NASDAQ:HZNP), signaling a renewed effort by antitrust enforcers to prevent mergers in the pharmaceutical industry. According to a person familiar with the matter, the FTC plans to seek an injunction in federal court to…